TC Biopharm (Holdings) Plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WOLVERINE ASSET MANAGEMENT LLC | 02/03/2025 | 668,324 | $6,616 | 100.00% | 2.22% |
| KEPOS CAPITAL LP | 02/11/2025 | 470,588 | $5,000 | 0.00% | 1.56% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 235,294 | $2,329 | 0.00% | 0.78% |
| CSENGE ADVISORY GROUP | 01/30/2025 | 23,862 | $236 | 26.51% | 0.08% |
| UBS GROUP AG | 02/14/2025 | 2,400 | $24 | 103.22% | 0.01% |
| ARMISTICE CAPITAL, LLC | 02/14/2025 | 188 | $2 | 100.00% | 0.00% |
| ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
TC Biopharm (Holdings) Plc institutional Ownership - FAQ's
During the previous two years, 10 institutional investors and hedge funds held shares of TC Biopharm (Holdings) Plc. The most heavily invested institutionals were:
WOLVERINE ASSET MANAGEMENT LLC: 668,324
Kepos Capital LP: 470,588
Nantahala Capital Management, LLC: 235,294
Csenge Advisory Group: 23,862
UBS Group AG: 2,400
ARMISTICE CAPITAL, LLC: 188
4.65% of TC Biopharm (Holdings) Plc stock is owned by institutional investors.
Institutional investors have bought a total of 4.22 M shares in the last 24 months. This purchase volume represents approximately $42,243 in transactions.